ProShare Advisors’s Krystal Biotech KRYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $911K | Sell |
|
|||||
|
2025
Q1 | $1.29M | Sell |
|
|||||
|
2024
Q4 | $1.39M | Buy |
|
|||||
|
2024
Q3 | $1.25M | Buy |
|
|||||
|
2024
Q2 | $946K | Sell |
|
|||||
|
2024
Q1 | $1.04M | Buy |
|
|||||
|
2023
Q4 | $667K | Buy |
|
|||||
|
2023
Q3 | $538K | Buy |
|
|||||
|
2023
Q2 | $526K | Buy |
|
|||||
|
2023
Q1 | $344K | Sell |
|
|||||
|
2022
Q4 | $386K | Buy |
|
|||||
|
2022
Q3 | $315K | Buy |
|
|||||
|
2022
Q2 | $285K | Sell |
|
|||||
|
2022
Q1 | $424K | Sell |
|
|||||
|
2021
Q4 | $493K | Buy |
|
|||||
|
2021
Q3 | $368K | Sell |
|
|||||
|
2021
Q2 | $588K | Buy |
|
|||||
|
2021
Q1 | $544K | Buy |
|
|||||
|
2020
Q4 | $362K | Buy |
|